Should we seek complete liver tests normalization in primary biliary cholangitis? Data from ColHai registry

被引：0

作者：

Diaz-Gonzalez, Alvaro ^{[1
]}

Rodriguez-Tajes, Sergio ^{[2
]}

Vergara Gomez, Mercedes ^{[3
]}

Fabrega, Emilio ^{[1
]}

Romero Gomez, Manuel ^{[4
]}

Albillos, Agustin ^{[5
]}

Gomez-Camarero, Judith ^{[6
]}

Horta, Diana ^{[7
]}

Gallego, Adolgo ^{[8
]}

Garcia-Retortillo, Montserrat ^{[9
]}

Andrade, Raul J. ^{[10
]}

Diago, Moises ^{[11
]}

Morillas, Rosa M. ^{[12
]}

Hernandez Guerra, Manuel ^{[13
]}

Ferre Aracil, Carlos ^{[14
]}

Sala, Margarita ^{[15
]}

Gomez Dominguez, Elena ^{[16
]}

Berenguer, Marina ^{[17
]}

Carlota Londono, Maria ^{[18
]}

del Registro, Grupo ^{[19
]}

机构：

[1] Hosp Marques de Valdecilla, Santander, Cantabria, Spain

[2] Hosp Clin Barcelona, Barcelona, Spain

[3] Hosp Univ Parc Tauli, Sabadell, Spain

[4] Hosp Univ Virgen Del Rocio, Seville, Spain

[5] Hos Univ Ramon y Cajal, Madrid, Spain

[6] Hosp Univ Burgos, Burgos, Spain

[7] Hosp Mutua Terrassa, Barcelona, Spain

[8] Hosp Santa Creu & Sant Pau, Barcelona, Spain

[9] Hosp del Mar, Barcelona, Spain

[10] Univ Malaga, Malaga, Spain

[11] Hopsital Univ Gen Valencia, Valencia, Spain

[12] Hosp Badalona Germans Trias & Pujol, Barcelona, Spain

[13] Hosp Univ Canarias, San Cristobal la Laguna, Spain

[14] Hosp Univ Puerta del Hierro, Madrid, Spain

[15] Hosp Josep Trueta, Girona, Catalonia, Spain

[16] Hosp Univ Doce Octubre, Madrid, Spain

[17] Hosp La Fe, Valencia, Spain

[18] Hosp Clin Barcelona, Liver Unit, Barcelona, Spain

[19] CIBEREHd, AEEH, Madrid, Spain

来源：

JOURNAL OF HEPATOLOGY | 2022年 / 77卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

THU482

引用

页码：S334 / S334

页数：1

共 50 条

[41] MODELING OF PRIMARY SCLEROSING CHOLANGITIS USING BILIARY SPHEROIDS DERIVED FROM BILE FLUID AND NEEDLE-LIVER BIOPSY SAMPLE
Mariotti, V.
Fantin, A.
Cadamuro, M.
Cagnin, S.
Fiorotto, R.
Floreani, A.
Guido, M.
Pontecorvi, V.
De Carlis, L.
Mutignani, M.
Cillo, U.
Strazzabosco, M.
Fabris, L.
DIGESTIVE AND LIVER DISEASE, 2020, 52 : S3 - S3
[42] CLINICAL SUPPORT USING DEEP LEARNING TO PREDICT THE NEED FOR INTERVENTION IN ELDERLY PATIENTS WITH PRIMARY BILIARY CHOLANGITIS FROM MULTICENTER DATA
Tonouchi, Takafumi
Kamimura, Hiroteru
Maruyama, Hiroki
Miida, Suguru
Sakai, Norihiro
Watanabe, Yusuke
Kimura, Naruhiro
Setsu, Toru
Abe, Hiroyuki
Yokoo, Takeshi
Sakamaki, Akira
Tsuchiya, Atsunori
Kamimura, Kenya
Terai, Shuji
HEPATOLOGY, 2023, 78 : S2039 - S2039
[43] Smoking as a risk factor for autoimmune liver disease: what we can learn from primary biliary cirrhosis
Smyk, Daniel S.
Rigopoulou, Eirini I.
Muratori, Luigi
Burroughs, Andrew K.
Bogdanos, Dimitrios P.
ANNALS OF HEPATOLOGY, 2012, 11 (01) : 7 - 14
[44] FACTORS ASSOCIATED WITH PROGRESSIVE COURSE OF PATIENTS WITH PRIMARY BILIARY CHOLANGITIS IN THE UNITED STATES: DATA FROM A LARGE-REAL WORLD DATABASE
Younossi, Zobair M.
Stepanova, Maria
Epstein, Robert
Strauss, Marcie
Golabi, Pegah
Nader, Fatema
Racila, Andrei
GASTROENTEROLOGY, 2018, 154 (06) : S1097 - S1097
[45] TREATMENT OF CHOLESTATIC PRURITUS IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS (PBC): BASELINE DATA FROM THE PHASE 2b GLIMMER TRIA
Smith, Helen
Das, Sugato
Currie, Alexander
De Souza, Andrea Ribeiro
McLaughlin, Megan M.
HEPATOLOGY, 2022, 76 : S1473 - S1474
[46] Cholestasis impacts on performance of non invasive tests for ruling out high-risk esophageal varices in patients with primary biliary cholangitis and compensated advanced chronic liver disease
Calvaruso, V.
Celsa, C.
Cristoferi, L.
Scaravaglio, M.
Capodicasa, L.
Di Maria, G.
Cadamuro, L.
Gerussi, A.
Malinverno, F.
Lampertico, P.
Cazzagon, N.
Marzioni, M.
Gentilucci, U. Vespasiani
Andreone, P.
De Nalda, A. Lleo
Rigamonti, C.
Vigano, M.
Giannini, E. G.
Russello, M.
Vanni, E.
Cerini, F.
Missale, G.
Brunetto, M.
Niro, G.
Vettori, G.
Castellaneta, A.
Cardinale, V.
Alvaro, D.
Mega, A.
Palitti, V. Pace
Bellanti, F.
Di Marco, V.
Invernizzi, P.
Camma, C.
Carbone, M.
DIGESTIVE AND LIVER DISEASE, 2024, 56 : S28 - S28
[47] CHOLESTASIS IMPACTS ON PERFORMANCE OF NON INVASIVE TESTS FOR RULING OUT HIGH-RISK ESOPHAGEAL VARICES IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS AND COMPENSATED ADVANCED CHRONIC LIVER DISEASE
Calvaruso, V.
Celsa, C.
Cristoferi, L.
Scaravaglio, M.
Capodicasa, L.
Di Maria, G.
Cadamuro, L.
Gerussi, A.
Malinverno, F.
Lampertico, P.
Cazzagon, N.
Marzioni, M.
Gentilucci, U. Vespasiani
Andreone, P.
Lleo, A.
Rigamonti, C.
Vigano, M.
Giannini, E. G.
Russello, M.
Vanni, E.
Cerini, F.
Missale, G.
Brunetto, M. R.
Niro, G.
Vettori, G.
Castellaneta, A.
Cardinale, V.
Alvaro, D.
Mega, A.
Pace, Palitti V.
Bellanti, F.
Di Marco, V.
Invernizzi, P.
Camma, C.
Carbone, M.
DIGESTIVE AND LIVER DISEASE, 2024, 56 : S153 - S154
[48] METABOLIC OUTCOMES AND KEY EFFICACY DATA FROM A PHASE 2 TRIAL EVALUATING COMBINATION OBETICHOLIC ACID AND BEZAFIBRATE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS
Bonder, Alan
Jones, Dave E.
Levy, Cynthia
Zou, Heng
Civitarese, Antonio
Nevens, Frederik
GASTROENTEROLOGY, 2024, 166 (05) : S1541 - S1542
[49] Identification of Helicobacter pylori and other Helicobacter species by PCR, hybridization, and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis
Nilsson, HO
Taneera, J
Castedal, M
Glatz, E
Olsson, R
Wadström, T
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (03) : 1072 - 1076
[50] PLN-74809, a clinical-stage, dual alphaVbeta6/alphaVbeta1 integrin inhibitor, reduces fibrosis in a preclinical model of biliary fibrosis and precision-cut liver slices from primary sclerosing cholangitis and primary biliary cholangitis patients
Schaub, Johanna
Chen, Chun
Decaris, Martin
Ho, Steve
Lee, Gail
Rao, Vikram
Marlow, Megan
Martin, Shamra
Chen, Tony
Wu, Jianfeng
Dooka, Christina
Cha, Jake
Munoz, Manuel
Leftheris, Katerina
Gorina, Eduard
Lefebvre, Eric
Turner, Scott
JOURNAL OF HEPATOLOGY, 2020, 73 : S97 - S98

← 1 2 3 4 5 →